PTS, Inc. (OTCPK:PTSH)
PTS, Inc. has entered into a Share Exchange Agreement pursuant to which PTSH will acquire 70% of ThinLine Technology Group at the closing. Closing shall occur as soon as PTSH receives satisfactory audited financials from ThinLine, but not later than December 31, 2010.
ThinLine Technology Group (www.thinlinegroup.com) manages, markets and maintains the IT and VOIP infrastructure for small and medium business (SMB market) and provides Private Cable Operators (PCO market) private label billing and call center support. At present, the company services over 21,000 clients on behalf of Private Cable Operators over 400 apartment properties across the United States.
In other PTSH news and events: In concert with recent merger news, PTSH. will shortly announce its new officers directors and board members, replacing current interim management.
PTS, Inc. does not have significant operations. PTSH intends to acquire undervalued businesses and/or merge with businesses with a history of operating revenues. Prior to February 23, 2010, PTSH engaged in the provision of accessibility compliance consulting services to government, school districts, and municipalities and other public entities, as well as to retail, commercial, recreational, and corporate customers. PTS, Inc. was founded in 1996 and is based in Las Vegas, Nevada.
To learn more about PTSH visit: http://www.ptspi.com
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc. Power3 plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company in the merger. The acquisition of Rozetta-Cell is expected to be completed in October or November 2010.
Rozetta-Cell is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. The company has a robust intellectual property portfolio and has created numerous products for adult stem cell therapy that are ready for market globally. Rozetta-Cell also has several collaborations in process through which it is partnering with industry-leading adult stem cell research companies and adult stem cell vendors.
Completion of the merger is subject to customary closing conditions, including receipt by the parties of all necessary board and shareholder approvals and third party consents. There can be no assurance that these conditions will be met or that the merger will be completed.
American International Group, Inc. (NYSE:AIG) reported a net loss attributable to AIG of $2.4 billion for the third quarter of 2010, or a loss of $17.62 per diluted common share, compared to net income of $455 million, or $0.68 per diluted common share, in the third quarter of 2009.
Income from continuing insurance operations was stable, at $2.1 billion.
The Board of Directors of Delphi Financial Group, Inc. (NYSE:DFG) declared a cash dividend of $0.11 per share on the Company’s common stock for the fourth quarter of 2010.
Such dividend will be payable on December 2, 2010 to shareholders of record at the close of business on November 18, 2010.
Ventas, Inc. (NYSE:VTR) reported that normalized Funds From Operations (“FFO”) for the quarter ended September 30, 2010 increased 11.7 percent to $115.4 million, from $103.4 million for the comparable 2009 period. Normalized FFO per diluted common share was $0.73 for the quarter ended September 30, 2010, an increase of 10.6 percent from $0.66 for the comparable 2009 period.
Weighted average diluted shares outstanding in the third quarter of 2010 rose by 0.9 percent to 157.9 million, compared to 156.5 million in the comparable 2009 period.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for PTS Inc. (OTCPK:PTSH)